Cite
HARVARD Citation
Marks, W. et al. (2019). Safety and efficacy of eculizumab in the prevention of antibody‐mediated rejection in living‐donor kidney transplant recipients requiring desensitization therapy: A randomized trial. American journal of transplantation. 19 (10), pp. 2876-2888. [Online].